5
Orphan Designations
0
FDA Approvals
17
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| acute graft versus host disease | CD5-T lymphocyte immunotoxin | Orphan Designation | - |
| atrioventricular block | Antimelanoma Antibody XMMME-001-DTPA 111 Indium | Orphan Designation | - |
| bone marrow cancer | Anti pan T lymphocyte monoclonal antibody | Orphan Designation | - |
| bone marrow failure syndrome | Anti pan T lymphocyte monoclonal antibody | Orphan Designation | - |
| bone marrow failure syndrome 5 | Anti pan T lymphocyte monoclonal antibody | Orphan Designation | - |
| bone marrow neoplasm | Anti pan T lymphocyte monoclonal antibody | Orphan Designation | - |
| chronic graft versus host disease | CD5-T lymphocyte immunotoxin | Orphan Designation | - |
| grade III prostatic intraepithelial neoplasia | Antimelanoma Antibody XMMME-001-RTA | Orphan Designation | - |
| graft versus host disease | CD5-T lymphocyte immunotoxinAnti pan T lymphocyte monoclonal antibody | Orphan Designation | - |
| heterotaxy, visceral, 5, autosomal | Antimelanoma Antibody XMMME-001-DTPA 111 Indium | Orphan Designation | - |
| metastatic malignant neoplasm in the colon | Anti-tap-72 immunotoxin | Orphan Designation | - |
| metastatic melanoma | Anti-tap-72 immunotoxin | Orphan Designation | - |
| metastatic neoplasm | Anti-tap-72 immunotoxin | Orphan Designation | - |
| nodal marginal zone B-cell lymphoma | Antimelanoma Antibody XMMME-001-DTPA 111 Indium | Orphan Designation | - |
| pulmonary fibrosis and/or bone marrow failure, telomere-related | Anti pan T lymphocyte monoclonal antibody | Orphan Designation | - |
| squamous carcinoma in situ | Antimelanoma Antibody XMMME-001-RTA | Orphan Designation | - |
| uterine cervix carcinoma in situ | Antimelanoma Antibody XMMME-001-RTA | Orphan Designation | - |